NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. ("Flowco" or "the Company") (NYSE:FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLOC.

High-quality assets like RTX and AbbVie are ideal for growth and income, offering inflation resilience and strong shareholder returns. RTX has a robust $217B backlog, rising global defense spending, robust margins, and a 32-year dividend growth streak, justifying its GARP valuation. AbbVie is rapidly replacing Humira revenue with high-growth drugs, maintains industry-leading margins, and delivers a 3.5% yield with double-digit EPS growth potential.

MEXICO CITY , June 2, 2025 /PRNewswire/ - DXC Technology, a leading Fortune 500 global technology services provider, today announced the relaunch of its DXC Fast RISE with SAP service in Mexico. This initiative gains new momentum following the recent availability of RISE with SAP, now hosted on Microsoft Azure, expanding opportunities to accelerate a cloud-based economy in Mexico through Microsoft's hyperscale datacenter region: Central Mexico.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. ("Meta" or "the Company") (NASDAQ:META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/META.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLGT.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GOCO.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NASDAQ:NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NPCE.

LOWELL, MA / ACCESS Newswire / June 2, 2025 / CSP Inc. (NASDAQ:CSPI), an award-winning provider of security and packet capture products, managed IT and professional services and technology solutions, today announced that it has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. "This is a significant milestone and reflects the excitement and growth potential of our emerging AZT PROTECT business," commented Victor Dellovo, Chief Executive Officer.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ:SMLR). Investors who purchased Semler securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SMLR.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ:TEM). Investors who purchased Tempus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TEM.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rocket Pharmaceuticals, Inc. ("Rocket" or "the Company") (NASDAQ:RCKT). Investors who purchased Rocket securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RCKT.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. ("ADTRAN" or "the Company") (NASDAQ:ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ADTN.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luminar Technologies, Inc. ("Luminar" or "the Company") (NASDAQ:LAZR). Investors who purchased Luminar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LAZR.

MINNEAPOLIS--(BUSINESS WIRE)--nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, today announced it will once again be a Minnesota Lynx Changemakers partner. After being an inaugural partner of the Lynx Changemakers program from the WNBA's Minnesota Lynx basketball team, nVent again chose to participate in the program as part of the company's ongoing commitment to building the next generation of leaders and promoting awareness of manufact.

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from the ENVISION and ATLAS clinical studies exploring investigational therapy UGN-102 (mitomycin) for intravesical solution for the treatment for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The data are featured at the 2025 American Society of Cli.

MILWAUKEE--(BUSINESS WIRE)--Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, has published the Fiserv Small Business Index for May 2025, with the seasonally-adjusted Index remaining flat at 151. Despite shifting spending patterns as consumers navigate near-term economic uncertainty, small businesses maintained solid year-over-year sales growth of (+3.3%) and total transactions rose (+3.8%). "Small businesses continue to show resilience, with May.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- #AI--Gigamon will showcase its Gigamon Deep Observability Pipeline at Cisco Live 2025, June 8-10 at the San Diego Convention Center.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:00 a.m. Eastern Daylight Time. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning t.

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Bitfarms Ltd. ("Bitfarms" or "the Company") (NASDAQ: BITF) for violations of the federal securities laws.

Catalyst (CPRX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.